Selected research
Market Structure
Global Gastrointestinal (GI) Stent Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Gastrointestinal (GI) Stent market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Gastrointestinal (GI) Stent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Gastrointestinal (GI) Stent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Gastrointestinal (GI) Stent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Gastrointestinal (GI) Stent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Gastrointestinal (GI) Stent include C.R. Bard, ConMed, Cook Medical, ELLA-CS, Gore Medical, Hobbs Medical, Merit Endotek, Olympus America and Taewoong Medical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Gastrointestinal (GI) Stent market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Gastrointestinal (GI) Stent and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Gastrointestinal (GI) Stent sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Gastrointestinal (GI) Stent market size, projected growth trends, production technologies, key applications, and end-use industries.
Gastrointestinal (GI) Stent Segment by Company
C.R. Bard
ConMed
Cook Medical
ELLA-CS
Gore Medical
Hobbs Medical
Merit Endotek
Olympus America
Taewoong Medical
Boston Scientific
Gastrointestinal (GI) Stent Segment by Type
Biliary Stents
Colonic Stents
Duodenal Stents
Esophageal Stents
Pancreatic Stents
Gastrointestinal (GI) Stent Segment by Application
Biliary Disease
Colorectal Cancer
Stomach Cancer
Gastrointestinal (GI) Stent Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gastrointestinal (GI) Stent market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Gastrointestinal (GI) Stent and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gastrointestinal (GI) Stent.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Gastrointestinal (GI) Stent market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gastrointestinal (GI) Stent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Gastrointestinal (GI) Stent in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Gastrointestinal (GI) Stent in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Biliary Stents
- Colonic Stents
- Duodenal Stents
- Esophageal Stents
- Pancreatic Stents
Applications
- Biliary Disease
- Colorectal Cancer
- Stomach Cancer
Companies covered
- C.R. Bard
- ConMed
- Cook Medical
- ELLA-CS
- Gore Medical
- Hobbs Medical
- Merit Endotek
- Olympus America
- Taewoong Medical
- Boston Scientific
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Gastrointestinal (GI) Stent Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Gastrointestinal (GI) Stent Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Gastrointestinal (GI) Stent Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Gastrointestinal (GI) Stent Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Gastrointestinal (GI) Stent Market Dynamics
- 2.1 Gastrointestinal (GI) Stent Industry Trends
- 2.2 Gastrointestinal (GI) Stent Industry Drivers
- 2.3 Gastrointestinal (GI) Stent Industry Opportunities and Challenges
- 2.4 Gastrointestinal (GI) Stent Industry Restraints
3 Gastrointestinal (GI) Stent Market by Manufacturers
- 3.1 Global Gastrointestinal (GI) Stent Revenue by Manufacturers (2021-2026)
- 3.2 Global Gastrointestinal (GI) Stent Sales by Manufacturers (2021-2026)
- 3.3 Global Gastrointestinal (GI) Stent Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Gastrointestinal (GI) Stent Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Gastrointestinal (GI) Stent Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Gastrointestinal (GI) Stent Manufacturers, Product Type & Application
- 3.7 Global Gastrointestinal (GI) Stent Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Gastrointestinal (GI) Stent Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Gastrointestinal (GI) Stent Players Market Share by Revenue in 2025
- 3.8.3 2025 Gastrointestinal (GI) Stent Tier 1, Tier 2, and Tier 3
4 Gastrointestinal (GI) Stent Market by Type
- 4.1 Gastrointestinal (GI) Stent Type Introduction
- 4.1.1 Biliary Stents
- 4.1.2 Colonic Stents
- 4.1.3 Duodenal Stents
- 4.1.4 Esophageal Stents
- 4.1.5 Pancreatic Stents
- 4.2 Global Gastrointestinal (GI) Stent Sales by Type
- 4.2.1 Global Gastrointestinal (GI) Stent Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Gastrointestinal (GI) Stent Sales by Type (2021-2032)
- 4.2.3 Global Gastrointestinal (GI) Stent Sales Market Share by Type (2021-2032)
- 4.3 Global Gastrointestinal (GI) Stent Revenue by Type
- 4.3.1 Global Gastrointestinal (GI) Stent Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Gastrointestinal (GI) Stent Revenue by Type (2021-2032)
- 4.3.3 Global Gastrointestinal (GI) Stent Revenue Market Share by Type (2021-2032)
5 Gastrointestinal (GI) Stent Market by Application
- 5.1 Gastrointestinal (GI) Stent Application Introduction
- 5.1.1 Biliary Disease
- 5.1.2 Colorectal Cancer
- 5.1.3 Stomach Cancer
- 5.2 Global Gastrointestinal (GI) Stent Sales by Application
- 5.2.1 Global Gastrointestinal (GI) Stent Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Gastrointestinal (GI) Stent Sales by Application (2021-2032)
- 5.2.3 Global Gastrointestinal (GI) Stent Sales Market Share by Application (2021-2032)
- 5.3 Global Gastrointestinal (GI) Stent Revenue by Application
- 5.3.1 Global Gastrointestinal (GI) Stent Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Gastrointestinal (GI) Stent Revenue by Application (2021-2032)
- 5.3.3 Global Gastrointestinal (GI) Stent Revenue Market Share by Application (2021-2032)
6 Global Gastrointestinal (GI) Stent Sales by Region
- 6.1 Global Gastrointestinal (GI) Stent Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Gastrointestinal (GI) Stent Sales by Region (2021-2032)
- 6.2.1 Global Gastrointestinal (GI) Stent Sales by Region (2021-2026)
- 6.2.2 Global Gastrointestinal (GI) Stent Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Gastrointestinal (GI) Stent Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Gastrointestinal (GI) Stent Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Gastrointestinal (GI) Stent Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Gastrointestinal (GI) Stent Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Gastrointestinal (GI) Stent Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Gastrointestinal (GI) Stent Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Gastrointestinal (GI) Stent Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Gastrointestinal (GI) Stent Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Gastrointestinal (GI) Stent Revenue by Region
- 7.1 Global Gastrointestinal (GI) Stent Revenue by Region
- 7.1.1 Global Gastrointestinal (GI) Stent Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Gastrointestinal (GI) Stent Revenue by Region (2021-2026)
- 7.1.3 Global Gastrointestinal (GI) Stent Revenue by Region (2027-2032)
- 7.1.4 Global Gastrointestinal (GI) Stent Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Gastrointestinal (GI) Stent Revenue (2021-2032)
- 7.2.2 North America Gastrointestinal (GI) Stent Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Gastrointestinal (GI) Stent Revenue (2021-2032)
- 7.3.2 Europe Gastrointestinal (GI) Stent Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Gastrointestinal (GI) Stent Revenue (2021-2032)
- 7.4.2 Asia-Pacific Gastrointestinal (GI) Stent Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Gastrointestinal (GI) Stent Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Gastrointestinal (GI) Stent Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 C.R. Bard
- 8.1.1 C.R. Bard Company Information
- 8.1.2 C.R. Bard Business Overview
- 8.1.3 C.R. Bard Gastrointestinal (GI) Stent Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 C.R. Bard Gastrointestinal (GI) Stent Product Portfolio
- 8.1.5 C.R. Bard Recent Developments
- 8.2 ConMed
- 8.2.1 ConMed Company Information
- 8.2.2 ConMed Business Overview
- 8.2.3 ConMed Gastrointestinal (GI) Stent Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 ConMed Gastrointestinal (GI) Stent Product Portfolio
- 8.2.5 ConMed Recent Developments
- 8.3 Cook Medical
- 8.3.1 Cook Medical Company Information
- 8.3.2 Cook Medical Business Overview
- 8.3.3 Cook Medical Gastrointestinal (GI) Stent Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Cook Medical Gastrointestinal (GI) Stent Product Portfolio
- 8.3.5 Cook Medical Recent Developments
- 8.4 ELLA-CS
- 8.4.1 ELLA-CS Company Information
- 8.4.2 ELLA-CS Business Overview
- 8.4.3 ELLA-CS Gastrointestinal (GI) Stent Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 ELLA-CS Gastrointestinal (GI) Stent Product Portfolio
- 8.4.5 ELLA-CS Recent Developments
- 8.5 Gore Medical
- 8.5.1 Gore Medical Company Information
- 8.5.2 Gore Medical Business Overview
- 8.5.3 Gore Medical Gastrointestinal (GI) Stent Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Gore Medical Gastrointestinal (GI) Stent Product Portfolio
- 8.5.5 Gore Medical Recent Developments
- 8.6 Hobbs Medical
- 8.6.1 Hobbs Medical Company Information
- 8.6.2 Hobbs Medical Business Overview
- 8.6.3 Hobbs Medical Gastrointestinal (GI) Stent Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Hobbs Medical Gastrointestinal (GI) Stent Product Portfolio
- 8.6.5 Hobbs Medical Recent Developments
- 8.7 Merit Endotek
- 8.7.1 Merit Endotek Company Information
- 8.7.2 Merit Endotek Business Overview
- 8.7.3 Merit Endotek Gastrointestinal (GI) Stent Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Merit Endotek Gastrointestinal (GI) Stent Product Portfolio
- 8.7.5 Merit Endotek Recent Developments
- 8.8 Olympus America
- 8.8.1 Olympus America Company Information
- 8.8.2 Olympus America Business Overview
- 8.8.3 Olympus America Gastrointestinal (GI) Stent Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Olympus America Gastrointestinal (GI) Stent Product Portfolio
- 8.8.5 Olympus America Recent Developments
- 8.9 Taewoong Medical
- 8.9.1 Taewoong Medical Company Information
- 8.9.2 Taewoong Medical Business Overview
- 8.9.3 Taewoong Medical Gastrointestinal (GI) Stent Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Taewoong Medical Gastrointestinal (GI) Stent Product Portfolio
- 8.9.5 Taewoong Medical Recent Developments
- 8.10 Boston Scientific
- 8.10.1 Boston Scientific Company Information
- 8.10.2 Boston Scientific Business Overview
- 8.10.3 Boston Scientific Gastrointestinal (GI) Stent Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Boston Scientific Gastrointestinal (GI) Stent Product Portfolio
- 8.10.5 Boston Scientific Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Gastrointestinal (GI) Stent Value Chain Analysis
- 9.1.1 Gastrointestinal (GI) Stent Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Gastrointestinal (GI) Stent Production Mode & Process
- 9.2 Gastrointestinal (GI) Stent Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Gastrointestinal (GI) Stent Distributors
- 9.2.3 Gastrointestinal (GI) Stent Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst